e-learning
resources
Monograph
2010
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sleep apnoea and systemic hypertension
M.R. Bonsignore, S. Battaglia, A. Zito, C. Lombardi, G. Parati
Source:
Eur Respir Monogr 2010; 50: 150-173
Journal Issue:
Sleep Apnoea out of print
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M.R. Bonsignore, S. Battaglia, A. Zito, C. Lombardi, G. Parati. Sleep apnoea and systemic hypertension. Eur Respir Monogr 2010; 50: 150-173
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Positive effect of CPAP treatment on the control of difficult-to-treat hypertension
Source: Eur Respir J 2007; 29: 951-957
Year: 2007
Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients
Source: Eur Respir J 2006; 27: 1229-1235
Year: 2006
Recommendations for the management of patients with obstructive sleep apnoea and hypertension
Source: Eur Respir J 2013; 41: 523-538
Year: 2013
CPAP treatment reduce blood pressure in patients with recent diagnosis of systemic hypertension and obstructive sleep apnoea -hypopnoea (OSAH). A controlled study
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008
Effect of compliance to continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 320s
Year: 2007
Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients?
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
Efficacy of continuous positive airway pressure treatment to resistant hypertension in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008
Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment
Source: Eur Respir J 2012; 39: 906-912
Year: 2012
Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005
CPAP and measures of cardiovascular risk in males with OSAS
Source: Eur Respir J 2008; 32: 1488-1496
Year: 2008
Effects of continuous positive airway pressure therapy in patients with severe obstructive sleep apnea and endothelial dysfunction on 24-hour blood pressure profile
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015
Screening of sleep apnea-induced hypertension and acute effect of continuous positive airway pressure
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Sleep-disordered breathing and hormones
Source: Eur Respir J 2003; 22: 161-172
Year: 2003
Influence of continuous positive airway pressure therapy on endothelial function and blood pressure in patients with arterial hypertension and obstructive sleep apnoea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006
Effect of continuous positive airway pressure therapy on metabolic control in patients with morbid obesity and obstructive sleep apnoea
Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing
Year: 2013
Can we correct the cardiovascular risks with treatment?
Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy
Year: 2005
Effectiveness of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnoea-hypopnoea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 682s
Year: 2006
The effect of positive airway pressure therapy on neurocognitive functions, depression and anxiety in obesity hypoventilation syndrome
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016
Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients
Source: Eur Respir J 2004; 23: 255-262
Year: 2004
Outcomes of OSA and indications for different therapies
Source: Eur Respir Mon 2010; 50: 225-243
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept